“When Patents Attack… Part II!” revisits old ground about bad IP actors by relying on half-truths and high drama. “This American Life,” an entertaining weekly
Category: Research
Trolls are Not the Only Bad Actors in Patent System, nor Most Damaging
Businesses that routinely steal others inventions are hoping that new legislation will make patent infringement more acceptable. When it comes to bad behavior so-called patent
Going Ape for Apps: Samsung is Gaga for U.S. Patents
No company has more Active U.S. patents than Samsung or files more applications. In fact, outside of IBM, Samsung leads all filers in U.S. patent
Public IP Cos (PIPCOs) – An Expanding Universe
IP-centric businesses whose shares trade on the public markets come in many shapes and sizes — some are better suited for return than others. Many of the most interesting
The NY Times Says Streaming Sticks it to Musicians
Royalties from so-called legitimate Internet streaming sites, including Pandora and Spotify, pay most musicians less than a penny on a dollar of revenue generated. In
Selling Prices of NPE-Owned Assets Lag Despite High Quality
Some buyers prefer to pay a premium for a large but still vague patent portfolio than for a handful of proven rights. “So, sue me,”
Liquidation Value of Alcatel IP Rights is said to be $3.9B to $5.9B
Bernstein Research and WSJ say that the company’s patent value is up to three times greater than its current market cap A credible news source
IBM’s Huge Lead in Patents: Under the Microscope
Big Blue may be caught in its image as the perennial patents-received leader, for better or worse. Obtaining large numbers of patents is often more
Leading Brands Increasingly have the Most Valuable Patents
Patent portfolios associated with strong positive reputation appear to enjoy better performance, or so it seems. It is no coincidence that many of the world’s
PwC to Wall Street: Largest Patent Damages Awards are Seldom Paid
Consulting Firm’s 2012 Study Shows the Most Active Venue for Patent Plaintiffs is Now Delaware, not Texas While it may appear in the media that
U.S. Cong. Research Service Wants Some Patent Holders to “PAE”
Flawed IP Report Attempts to Legitimize Assertion Label If the Congressional Research Service’s distorted findings on the impact of patent holders are not bad enough,
Low R&D Cost Per-Patent is a Poor Indicator of Good Return
Patent Yield-Per-R&D Dollar Varies Widely by Industry, Technology & Business Model For most businesses obtaining patents and costly R&D go together like love and marriage
ipcloseup.com 